Breast tumor localization using sestamibi

Clinical Nuclear Medicine

Volumn 27, Issue 3, 2002, Pages 161-164

  Coover, Leonard R ^a   Malaspina, Paul J ^a  

^a HAMOT MEDICAL CENTER   (United States)

Author keywords

Breast Cancer Detection; Sestamibi

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TUMOR MARKER;

ADENOCARCINOMA; ADULT; ARTICLE; BREAST BIOPSY; BREAST TUMOR; CANCER DIAGNOSIS; CANCER GRADING; CASE REPORT; CLINICAL EXAMINATION; DIAGNOSTIC IMAGING; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; MAMMOGRAPHY; RISK BENEFIT ANALYSIS; TUMOR LOCALIZATION;

BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PALPATION; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI;

EID: 0036197158     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200203000-00001     Document Type: Article

References (21)

1. Scintimammography in patients with minimal mammographic or clinical findings
2. The role of technetium-99m methoxyisobutylisonitrile scintimammography in the diagnosis of breast cancer in patients with mammographically dense breasts
3. Prediction of the usefulness of combined mammography and scintimammography in suspected primary breast cancer using ROC curves
4. The role of Tc-99m methoxyisobutylisonitrile scintimammography as compared to mammography in evaluating palpable breast masses of Taiwanese women
5. 99Tcm-MIBI scintimammography in 300 consecutive patients: Factors that may affect accuracy
6. Sensitivity and specificity of planar scintimammography with 99m Tc-sestamibi
7. The role of 99m Tc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis
8. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions
9. Comparison of technetium-99m-sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions
10. Technetium-99m-MIBI scintimammography for suspicious breast lesions
11. Prone scintimammography in patients with suspicion of carcinoma of the breast
12. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement
13. In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: Comparison with technetium-99m-sestamibi and thallium-201
14. Future directions in imaging of breast diseases
15. Scintimammography with technetium-99m-methoxyisobutylisonitrile: Results of a prospective European multicentre trial
16. Scintimammography: The complimentary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma
17. Mammographic characteristics of 115 missed cancers later detected with screening mammography and the potential utility of computer-aided detection
18. Breast density as a predictor of mammographic detection: Comparison of interval- and screen-detected cancers
19. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: Review of 183,134 screening mammograms in Albuquerque, New Mexico
20. The use of external radioactive markers in scintimammography
21. Double-phase 99mTc-sestamibi scintimammography and trans-scan in diagnosing breast cancer